Search

Your search keyword '"Lonn E"' showing total 412 results

Search Constraints

Start Over You searched for: Author "Lonn E" Remove constraint Author: "Lonn E"
412 results on '"Lonn E"'

Search Results

2. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

4. Early Initiation of Sacubitril/Valsartan in Patients With Acute Heart Failure and Renal Dysfunction: An Analysis of the TRANSITION Study

5. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

6. Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk

7. Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke

9. Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials

10. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study

11. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

12. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk

13. Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study

14. Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study

15. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study

17. Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative

18. Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk

19. Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke

21. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

24. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140mmHg) and cardiovascular outcomes in high-risk patients: Results fromONTARGET and TRANSCEND trials

25. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

26. Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials

28. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

30. Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease

32. Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial

33. Metformin in adults with type 1 diabetes

37. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

41. Evolocumab and clinical outcomes in patients with cardiovascular disease

43. P1637Rehospitalisations during 26 weeks of follow up from initiation of sacubitril/valsartan after acute decompensated heart failure: An analysis of the TRANSITION study

44. P773Initiation of sacubitril/valsartan and optimisation of evidence-based heart failure therapies after hospitalisation for acute decompensated heart failure: An analysis of the TRANSITION study

45. In-Hospital Initiation of Sacubitril/Valsartan in Stabilised Patients with Heart Failure and Reduced Ejection Fraction Naïve to Renin-Angiotensin System Blocker: An Analysis of the Transition Study

46. Initiation of Sacubitril/Valsartan in Patients with De Novo Heart Failure with Reduced Ejection Fraction: An Analysis of the Transition Study

47. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

48. Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial

49. Resting heart rate is associated with renal disease outcomes in patients with vascular disease: Results of the ONTARGET and TRANSCEND studies

50. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL) : a double-blind, randomised, placebo-controlled trial

Catalog

Books, media, physical & digital resources